Literature DB >> 30731173

Coffee, tea, caffeine, and risk of nonmelanoma skin cancer in a Chinese population: The Singapore Chinese Health Study.

Choon Chiat Oh1, Aizhen Jin2, Jian-Min Yuan3, Woon-Puay Koh4.   

Abstract

BACKGROUND: Although epidemiologic studies in populations of European descent suggest a possible chemoprotective effect of caffeine against nonmelanoma skin cancer (NMSC), data in Asian populations are lacking.
OBJECTIVES: We examined the relationship of coffee, tea, and caffeine consumption with NMSC risk among Chinese in Singapore.
METHODS: We used data from the Singapore Chinese Health Study, a prospective cohort of 63,257 men and women who were 45 to 74 years old at recruitment from 1993 to 1998. Hazard ratios (HRs) and 95% confidence intervals (CIs) were estimated by using multivariable Cox proportional hazard models.
RESULTS: Coffee drinking was associated with reduced NMSC risk in a dose-dependent manner (P trend < .0001). Compared with those who drank coffee less than weekly, those who drank 3 or more cups per day had a lower risk of basal cell carcinoma (HR, 0.54; 95% CI, 0.31-0.93) and a lower risk of squamous cell carcinoma (HR, 0.33; 95% CI, 0.13-0.84). Compared with nondrinkers of black tea, daily drinkers of black tea also had a reduced risk of NMSC (HR, 0.70; 95% CI, 0.52-0.94). Caffeine intake reduced NMSC risk in a stepwise manner (P trend = .0025); subjects with a caffeine intake of 400 mg/d or more had the lowest risk (HR, 0.59; 95% CI, 0.34-1.04).
CONCLUSION: Consumption of caffeinated drinks such as coffee and black tea may reduce the risk of NMSC among Chinese.
Copyright © 2019 American Academy of Dermatology, Inc. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Chinese; caffeine; coffee; nonmelanoma skin cancer; tea

Mesh:

Substances:

Year:  2019        PMID: 30731173      PMCID: PMC9247871          DOI: 10.1016/j.jaad.2019.01.084

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN: 0190-9622            Impact factor:   15.487


  26 in total

Review 1.  The pathogenesis of melanoma induced by ultraviolet radiation.

Authors:  B A Gilchrest; M S Eller; A C Geller; M Yaar
Journal:  N Engl J Med       Date:  1999-04-29       Impact factor: 91.245

2.  ATR inhibition selectively sensitizes G1 checkpoint-deficient cells to lethal premature chromatin condensation.

Authors:  P Nghiem; P K Park; Y Kim ; C Vaziri; S L Schreiber
Journal:  Proc Natl Acad Sci U S A       Date:  2001-07-31       Impact factor: 11.205

3.  Black Tea Consumption and Risk of Skin Cancer: An 11-Year Prospective Study.

Authors:  Kyoko Miura; Maria Celia B Hughes; Novita Intan Arovah; Jolieke C van der Pols; Adèle C Green
Journal:  Nutr Cancer       Date:  2015-09-11       Impact factor: 2.900

4.  Coffee consumption and risk of nonmelanoma skin cancer: a dose-response meta-analysis.

Authors:  Golnaz Vaseghi; Shaghayegh Haghjoo-Javanmard; Jamal Naderi; Azadeh Eshraghi; Manijeh Mahdavi; Marjan Mansourian
Journal:  Eur J Cancer Prev       Date:  2018-03       Impact factor: 2.497

5.  Caffeine intake and risk of basal cell and squamous cell carcinomas of the skin in an 11-year prospective study.

Authors:  Kyoko Miura; Maria Celia B Hughes; Adèle C Green; Jolieke C van der Pols
Journal:  Eur J Nutr       Date:  2013-07-04       Impact factor: 5.614

6.  Survival after squamous cell and basal cell carcinoma of the skin: A retrospective cohort analysis.

Authors:  Margaret R Karagas; Janet L Peacock; Judy R Rees; M Scot Zens; Maria O Celaya; Bruce L Riddle
Journal:  Int J Cancer       Date:  2015-01-29       Impact factor: 7.396

7.  No end in sight: the skin cancer epidemic continues.

Authors:  Matthew R Donaldson; Brett M Coldiron
Journal:  Semin Cutan Med Surg       Date:  2011-03

8.  Effect of caffeine on the ATR/Chk1 pathway in the epidermis of UVB-irradiated mice.

Authors:  Yao-Ping Lu; You-Rong Lou; Qing-Yun Peng; Jian-Guo Xie; Paul Nghiem; Allan H Conney
Journal:  Cancer Res       Date:  2008-04-01       Impact factor: 12.701

9.  Basal cell carcinoma, squamous cell carcinoma and melanoma of the skin: analysis of the Singapore Cancer Registry data 1968-97.

Authors:  D Koh; H Wang; J Lee; K S Chia; H P Lee; C L Goh
Journal:  Br J Dermatol       Date:  2003-06       Impact factor: 9.302

10.  A meta-analysis of pigmentary characteristics, sun sensitivity, freckling and melanocytic nevi and risk of basal cell carcinoma of the skin.

Authors:  Mohammad Khalesi; David C Whiteman; Bich Tran; Michael G Kimlin; Catherine M Olsen; Rachel E Neale
Journal:  Cancer Epidemiol       Date:  2013-07-10       Impact factor: 2.984

View more
  5 in total

Review 1.  Deciphering UV-induced DNA Damage Responses to Prevent and Treat Skin Cancer.

Authors:  Jihoon W Lee; Kajan Ratnakumar; Kai-Feng Hung; Daiki Rokunohe; Masaoki Kawasumi
Journal:  Photochem Photobiol       Date:  2020-05-04       Impact factor: 3.421

2.  Caffeine enhances the anti-tumor effect of 5-fluorouracil via increasing the production of reactive oxygen species in hepatocellular carcinoma.

Authors:  Zhilei Wang; Chengxin Gu; Xinrui Wang; Yating Lang; Yanqin Wu; Xiaoqin Wu; Xifei Zhu; Kunyuan Wang; Hui Yang
Journal:  Med Oncol       Date:  2019-10-29       Impact factor: 3.064

3.  The Coffee-Acrylamide Apparent Paradox: An Example of Why the Health Impact of a Specific Compound in a Complex Mixture Should Not Be Evaluated in Isolation.

Authors:  Astrid Nehlig; Rodrigo A Cunha
Journal:  Nutrients       Date:  2020-10-14       Impact factor: 5.717

4.  Antitumor Effects of Freeze-Dried Robusta Coffee (Coffea canephora) Extracts on Breast Cancer Cell Lines.

Authors:  Ayelén D Nigra; Deborah de Almeida Bauer Guimarães; César G Prucca; Otniel Freitas-Silva; Anderson J Teodoro; Germán A Gil
Journal:  Oxid Med Cell Longev       Date:  2021-05-18       Impact factor: 6.543

Review 5.  Anti-Cancer Effects of Green Tea Epigallocatchin-3-Gallate and Coffee Chlorogenic Acid.

Authors:  Sumio Hayakawa; Tomokazu Ohishi; Noriyuki Miyoshi; Yumiko Oishi; Yoriyuki Nakamura; Mamoru Isemura
Journal:  Molecules       Date:  2020-10-05       Impact factor: 4.411

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.